XML 42 R24.htm IDEA: XBRL DOCUMENT
v3.22.1

Intangible Assets and Goodwill (Tables) | 3 Months Ended
--- | ---
Apr. 03, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets and Goodwill |
(Dollars in Millions) |  | April 3, 2022 |  | January 2, 2022
Intangible assets with definite lives: |  |  |  |
Patents and trademarks — gross |  | $ | 37,960 |  |  | 38,572 |
Less accumulated amortization |  | (20,492) |  |  | (20,088) |
Patents and trademarks — net |  | 17,468 |  |  | 18,484 |
Customer relationships and other intangibles — gross |  | 22,910 |  |  | 23,011 |
Less accumulated amortization |  | (12,147) |  |  | (11,925) |
Customer relationships and other intangibles — net(1) |  | 10,763 |  |  | 11,086 |
Intangible assets with indefinite lives: |  |  |  |
Trademarks |  | 6,947 |  |  | 6,985 |
Purchased in-process research and development(2) |  | 9,242 |  |  | 9,837 |
Total intangible assets with indefinite lives |  | 16,189 |  |  | 16,822 |
Total intangible assets — net |  | $ | 44,420 |  |  | 46,392 |
(1)The majority is comprised of customer relationships (2)In the fiscal first quarter of 2022, the Company recorded an intangible asset impairment charge of approximately $0.6 billion related to an in-process research and development asset, bermekimab (JnJ-77474462), an investigational drug for the treatment of Atopic Dermatitis (AD) and Hidradenitis Suppurativa (HS). Additional information regarding efficacy of the AD indication became available which led the Company to the decision to terminate the development of bermekimab for AD. The Company acquired all rights to bermekimab from XBiotech, Inc.in the fiscal year 2020.
Goodwill | Goodwill as of April 3, 2022 was allocated by segment of business as follows:
(Dollars in Millions) |  | Consumer Health |  | Pharmaceutical |  | MedTech |  | Total
Goodwill at January 2, 2022 |  | $ | 9,810 |  |  | 10,580 |  |  | 14,856 |  |  | 35,246 |
Goodwill, related to acquisitions |  | — |  |  | — |  |  | 73 |  |  | 73 |
Currency translation/Other |  | (195) |  |  | (170) |  |  | (19) |  |  | (384) |
Goodwill at April 3, 2022 |  | $ | 9,615 |  |  | 10,410 |  |  | 14,910 |  |  | 34,935 |
Intangible Asset Amortization Expense | The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:
(Dollars in Millions) |  |  |  |  |  |
2022 |  | 2023 |  | 2024 |  | 2025 |  | 2026
$4,600 |  | 4,600 |  | 4,400 |  | 3,600 |  | 3,000

X
- Definition Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block] + References No definition available. + Details
Name: | jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock
Namespace Prefix: | jnj_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration